N@N

Whitney Ijem Initiated (BMRN) at Hold and Held Target at $119 on, Jan 18th, 2023

Whitney Ijem of Canaccord Genuity, Initiated "BioMarin Pharmaceutical Inc." (BMRN) at Hold and Held Target at $119 on, Jan 18th, 2023.

Whitney has made no other calls on BMRN in the last 4 months.

There are 7 other peers that have a rating on BMRN. Out of the 7 peers that are also analyzing BMRN, 2 agree with Whitney's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Andreas Argyrides of "Wedbush" Maintained at Hold with Increased Target to $83 on, Wednesday, January 11th, 2023
• Luca Issi of "RBC Capital" Maintained at Hold with Increased Target to $95 on, Thursday, October 13th, 2022

These are the ratings of the 5 analyists that currently disagree with Whitney

---

• Akash Tewari of "Jefferies" Maintained at Strong Buy with Increased Target to $120 on, Tuesday, November 29th, 2022
• Leland Gershell of "Oppenheimer" Upgraded from Hold to Buy and Increased Target to $110 on, Monday, October 31st, 2022
• Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $113 on, Thursday, October 27th, 2022
• Tiago Fauth of "Credit Suisse" Maintained at Buy with Decreased Target to $110 on, Thursday, October 27th, 2022
• Jessica Fye of "JP Morgan" Maintained at Buy with Decreased Target to $112 on, Monday, October 24th, 2022

Contributing Sources

---